Real-time enrollment status for this major depressive disorder clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 7:54 AM UTC
| NCT Number | NCT07196501 |
| Recruiting Status | Recruiting |
| Condition | Major Depressive Disorder |
| Phase | PHASE3 |
| Target Enrollment | 550 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Neurocrine Biosciences |
| Last Updated on CT.gov | March 19, 2026 (Mar 19, 2026) |
As of July 19, 2026: Clinical trial NCT07196501 is currently recruiting participants. This phase3 study for major depressive disorder is actively seeking new participants at 18 locations across the United States. The study is sponsored by Neurocrine Biosciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07196501 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07196501 was last updated Mar 19, 2026 (March 19, 2026). HelloStudys verifies this status automatically.